Study finds cancer programs in Michigan follow care guidelines for common cancers
A majority of Michigan oncology practices participating in a statewide consortium followed treatment guidelines for common cancers, but had gaps in managing symptoms and end-of-life care, according to a new study. The study comes out of the Michigan Oncology Quality Consortium, a statewide collaboration among medical oncology practices, the American Society of Clinical Oncology, the University of Michigan Comprehensive Cancer Center and Blue Cross Blue Shield of Michigan, designed to collect data from medical oncology practices about how physicians care for cancer patients. Results of the study appear in the April issue of Health Affairs.
Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.